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ABSTRACT

Transition Services for Parolees with Co-Occurring
Substance Use and Mental Health Disorders
Michaela Elizabeth Huber
Department of Sociology, BYU
Master of Science
A large portion of U.S. inmates and parolees experience co-occurring substance use and
mental health disorders (COD). Offenders with COD exhibit significantly poorer outcomes than
offenders who do not have COD, including less time to rearrest and reincarceration. Research
shows that transition services for substance use and mental health disorders improve parolee
outcomes, yet a majority of offenders with COD do not receive transition services prior to
discharge or upon release from correctional facilities. Using a nationally representative sample
of offenders with COD (secondary data from the CJ-DATS; N=811), this study analyzes the
treatment effects of Transition Case Management (TCM) on parolees’ drug use, rearrest, and
reincarceration during the first nine months of parole, on a sample of offenders with COD.
Results indicate there are no statistically significant differences between TCM treatment and
control groups when predicting likelihood of rearrest, reincarceration, and drug use.
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INTRODUCTION
The Bureau of Justice Statistics (BJS) has estimated that up to 42 percent of prison
inmates and 49 percent of jail inmates experience co-occurring mental health and substance use
disorders (COD) (James & Glaze 2006). Prison inmates with COD exhibit significantly poorer
outcomes than inmates who do not have COD (Baillargeon et al. 2010; Fletcher et al. 2009;
Peters, Wexler, & Lurigio 2015). One study of Texas parolees reported that COD parolees were
two times more likely to violate parole within one year, and two and one-half times more likely
to commit a new crime than parolees with no disorders (Baillargeon et al. 2009). Data from a
nationally representative sample found that parolees with COD were rearrested, on average, five
months sooner than those with a serious mental illness (SMI), and three months sooner than
parolees with a substance use disorder (SUD) (Wood 2014).
Successful outcomes for COD offenders depend largely on the quality of systems
integration and continuum of care as they progress through different phases of the criminal
justice system (Butzin & Inciardi 2002; Taxman & Bouffard 2000). Ideally, a continuum of care
includes prison-based treatment, transition services, and community-based aftercare treatment.
Transition services, which typically begin while parolees are still incarcerated shortly before
their release, include strengths and needs assessments, discharge planning, and treatment
referrals. Transition services also include any short-term services or care received immediately
following release from prison, such as intensive treatment offered by halfway houses or
residential treatment facilities (Butzin, Martin, & Inciardi 2005; De Leon 2000).
At this point, very few controlled studies have been conducted on specialized COD
transition services or aftercare treatment in criminal justice settings, and experts have yet to
produce any best practice policies or standards. Researchers have linked transition services and
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aftercare treatment, noting a directional association between an absence of transition services,
and low engagement in community-based aftercare treatment, as well as other unsuccessful
outcomes (Fletcher et al. 2009; Freudenberg 2001). Conversely, research demonstrates a
significant association between receiving transition services and increased rates of participation
in community-based aftercare treatment, for inmates and parolees with SUD only and SMI only.
There is clear justification for clinical examination of transition services adapted for COD
offenders. The quality of transition services for COD offenders and their access to them
becomes a more poignant issue when considering previous findings from studies of SMI and
SUD offenders. Research on treatment modalities for the COD correctional population is
necessary in order to improve their long term criminogenic and health outcomes. It is not
responsible to assume that preexisting treatments for general or single disorder offenders will be
effective for treating co-occurring disorders.
The present study examines the effects of receiving transition services on parolee drug
use and criminal recidivism outcomes. Secondary Criminal Justice Drug Abuse Studies (CJDATS) data from a previously conducted study on Transition Case Management (TCM), a
model of care created for soon-to-be-released inmates, meant to increase their participation in
community aftercare drug treatment (Prendergast & Cartier 2004). Previous analysis of TCM
has not accounted for offenders’ COD diagnosis status when predicting behavioral and criminal
recidivism outcomes. The purpose of this study is to extend our understanding of TCM and its
utility by accounting for parolees’ COD. The statistical analysis performed allows experts to
form more conclusive judgments regarding the efficacy of this treatment model to successfully
refer and place parolees in community-based aftercare treatment, and reduce criminal recidivism
among parolees with COD.
2

BACKGROUND
Substance Use Disorders and Treatment in Correctional Facilities
Extensive research has been conducted on the frequency and treatment of substance use
and mental health disorders among inmates in the United States; conversely, research on
offenders with COD is limited. Upon reviewing studies of offenders with SUD and SMI, a
subsequent section discusses available research on COD offenders, and the current issues and
concerns surrounding their treatment in the correctional system. The BJS reports that 74 percent
of state prisoners and 76 percent of jail inmates have an SUD (James & Glaze 2006), and other
sources estimate that as many as 85 percent of all federal, state, and local inmates have a history
of regular illicit drug use (George et al. 2012). Offenders with SUD struggle with community
reintegration and display high rates criminal recidivism. National Data gathered by the BJS
reported that within three years of release, 67 percent of drug offenders were rearrested, and
approximately 49 percent were reincarcerated (Langan & Levin 2002).
It is widely accepted that prison-based drug treatment can effectively reduce future drug
use and criminal recidivism among offenders with SUD (Butzin & Inciardi 2002; Simpson
2004). In particular, Therapeutic Communities (TC) is one of the most effective treatment
models of prison-based drug treatment, with higher rates of success than low-intensity
treatments. Studies of prison-based TC report significant treatment effects including reductions
in criminal recidivism (Wexler et al. 1992; McCollister et al. 2003).
Despite the overwhelming need to provide rehabilitation to inmates, drug treatment is yet
to be universally provided by U.S. state and federal prisons. While drug education and other
low-intensity services are typically offered by local and state correctional facilities, intensive
prison-based drug treatment is available in a small portion of these institutions: only 29 percent
3

of prisons and 27 percent of jails offer intensive Therapeutic Communities (TC) drug treatment
(McCarty & Chandler 2009). Additionally, even when correctional facilities do offer such
treatments it is not guaranteed that all eligible inmates will have access to them. One 2005 report
estimated that only 12.4 percent of inmates with a history of drug use receive any clinically or
medically based drug treatment while incarcerated (Belenko & Peugh 2005). More recently, two
studies found that only 15 percent of their sample of substance abusing inmates had received any
treatment from a trained professional since prison admission (Belenko & Houser. 2012; Fletcher
et al. 2009).
Obstacles to Successful Treatment Outcomes
Although widely recognized as an effective form of rehabilitation, even when
administered properly, prison-based drug treatment must not be considered a “fix-all” solution
for reducing future substance use and criminal recidivism. Research has shown that successful
treatment outcomes are not always sustained longitudinally. Many follow-up studies have
reported that initial significant differences in reincarceration rates between inmates who receive
drug treatment and their untreated peers will decrease or become nonexistent over time (Larney
et al. 2011; Martin et al. 1999; Prendergast, Wellisch, & Wong 1996; Wexler et al. 1999).
Prison-based treatment effects are often contingent upon several variables. For example,
one issue affecting the quality of prison-based treatment is duration. It is well established that
treatment must last a minimum of 90 days in order to show significant long-term changes in drug
use and recidivism (Coviello et al. 2013; Friedmann, Taxman, & Henderson 2007; Hser et al.
2001; Simpson et al. 1997), yet research shows that only one-third of inmates actually complete
90 days of drug treatment (Longshore et al. 2004; Zanis et al. 2009). One randomized controlled
trial of a methadone maintenance treatment program in Baltimore found that initially, prisoners
4

who received treatment were less likely to be reincarcerated than the control group, but this
effect became statistically nonsignificant by six months post incarceration (Gordon et al. 2008;
Kinlock et al. 2008.) Research also indicates that prison-based drug treatment may even be
entirely ineffective when treating certain SUD’s. A series of studies in the U.S. and France
found that among heroin users, prison-based Opioid Substitution Treatment (OST) produced no
significant difference in reincarceration rates between treatment and control groups (Johnson,
van de Ven, & Grant 2001; Levasseur et al. 2002).
Mental Health Disorders and Treatment in Correctional Facilities
It is estimated that 56 percent of prison inmates and 64 percent of jail inmates have been
clinically diagnosed with mental health problems, and 26 percent of all incarcerated offenders
have been diagnosed with an SMI (James & Glaze 2006). However, it should be emphasized
that these figures are estimates; the accuracy of these statistics is unclear, due to the frequency of
jail and prison inmates with undetected mental health problems and SMI.
Persons with SMI are 50 percent more likely to be incarcerated than hospitalized for
treatment (Morrissey, Meyer, & Cuddeback 2007). Only 3 percent of the general population
experience SMI (non-institutionalized civilians), while 15 percent of the total correctional
supervision (i.e., jails, prisons, probation) have SMI (Kaeble et al. 2016; Torrey et al. 2014). The
number of persons with SMI in U.S. jails and prisons is now three times larger than the public
psychiatric hospital population (Torrey et al. 2014). Many experts attribute the high rates of SMI
in U.S. correctional facilities to key legislative decisions that have resulted in the closure of
many state psychiatric hospitals, which has arguably caused a migration of mental health
treatment from state hospitals to correctional facilities (Grob 1995; Grob 2008; Lurigio 2001;
Torrey et al. 2014). The number of patients in state hospitals has been in consistent decline since
5

1960, and between 2005 and 2010 the number of beds in state psychiatric hospitals decreased by
14 percent (SAMHSA 2012).
Offenders with SMI serve a larger proportion of their sentences, serve longer sentences,
and are more likely to recidivate than the general offender population (O’Connor, Lovell, &
Brown 2002). One study found that upon release former inmates with a professionally
diagnosed SMI were 70 percent more likely to be reincarcerated at least once than ex-inmates
who did not have SMI(Gonzalez & Connell 2014).
Few empirical studies have investigated effective therapies for inmates with SMI, and a
large portion of clinical examination that does take place has been conducted outside the U.S.
There are several evidence-based models used to treat criminal behavior among general
offenders including Cognitive Behavioral Therapy (CBT) and Social Learning Theory (Bourgon
& Armstrong 2005; Morgan et al. 2012; Morgan & Flora 2002; Wormith & Olver 2002), but
treatment experts have warned that these practices will not necessarily be effective on offenders
with SMI (Morgan et al. 2014). Furthermore, it is important to understand that while some
mental health treatment may improve psychiatric outcomes for the general population, not all
treatment models are designed to treat patterns of criminality exhibited by offenders with SMI
(Andrews & Bonta 2010; Morgan et al. 2014). In order to treat mental illness and criminal
behavior, offenders with SMI must receive integrated and comprehensive treatment informed by
both correctional strategies and psychiatric guidelines.
Despite federal policy mandating that all incarcerated offenders are to receive medical
and mental health care, many inmates with mental health problems or SMI go undetected and
untreated (Pillai et al. 2016). The need to improve frequency and quality of screenings,
diagnosis, and treatment of SMI in correctional institutions is both a legal and humanitarian issue
6

(Gonzalez & Connell 2014). Yet, providing mental health treatment in jails and prisons is
complex. Administers face many practical challenges, and few regimens employ evidence-based
practices (EBP’s) (George et al. 2012).
Screenings and diagnosis play a large role in whether an inmate will receive treatment:
prison staff members with no professional background in the field of mental health are often
responsible for assessing and referring inmates to various forms of treatment (Lurigio 2006). In
this scenario, while accessible, administrators rarely utilize EBP’s in the screening and diagnosis
process. This, in turn, significantly decreases the likelihood that an SMI will be diagnosed,
especially when considering the myriad symptoms associated with various SMI’s that are
impossible to detect without assessment from a trained mental health professional (O’Connor et
al. 2002). These issues have a negative effect from a research perspective: “little is known about
the number of inmates who need different amounts or types of treatment, in part because of the
absence of standardized and validated clinical screening and assessment in correctional
facilities” (Belenko & Peugh 2005:270). Even when EBP’s are implemented in correctional
facilities, research shows this does not result in a higher rate of prison-based mental health
treatment received by inmates (Pillai et al. 2016).
Furthermore, disciplinary actions that take place in prison facilities can prevent inmates
from receiving mental health treatment. Many inmates with SMI end up in solitary confinement
due to behavioral disciplinary action, eliminating their opportunity to receive mental health
treatment (Butler, Johnson, & Griffin 2014; Gonzalez & Connell 2014). Budgetary restrictions
may also prevent inmates from receiving proper mental health care. Many correctional facilities
cannot provide or opt out of providing pharmacotherapy (use of medications in mental health
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treatment), which can be a significant component in comprehensive mental health treatment
(Gonzalez & Connell 2014).
Transition Services and Community-Based Aftercare Treatment
Experts agree that prison-based treatment is just one component of a comprehensive
treatment system and longitudinal continuum of care for offenders with SUD and SMI. Research
suggests that prison-based treatment effects often depend upon parolee engagement in
community-based aftercare treatment. A large amount of evidence confirms the importance of
transition services, especially for offenders who have completed prison-based treatment
(Earthrowl, O'Grady, & Birmingham 2003; Sacks et al. 2012; Simpson 2004; Knight, Simpson,
& Hiller 1999; Martin et al. 1999; Wolff et al. 2002). Studies have also demonstrated the costeffectiveness of transition services; a longitudinal analysis of a Texas-based continuum of care
program found that a three-tiered service program (prison-based treatment, residential aftercare,
and outpatient aftercare) was cost-effective only when participants completed the entire
treatment regimen (Griffith et al. 1999).
Studies of SMI transition services also demonstrate many successful outcomes. One
study of SMI offenders found that reincarceration rates for those who received both prison-based
treatment and aftercare were almost half the rate of the control group that received a standard
mental health treatment (17 percent vs. 33 percent) (Sacks et al. 2004).
Research has shown that standard outpatient treatments as well as residential communitybased treatments are both reliable and cost-effective methods of aftercare, especially for highrisk parolees with SUD or SMI (Griffith et al. 1999; Simpson 2004). Treatment effects include
reduced substance use (French et al. 2002; Lipton et al. 2003; Fletcher et al. 2009), improved
psychological well-being (Sacks et al. 2012), and larger reductions in recidivism for longer
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periods of time in comparison to control groups (De Leon 1984; De Leon & Jainchill 1981; De
Leon et al. 1999; De Leon et al. 2000; Hiller, Knight, & Simpson 1999; Sacks, Sacks, &
Stommel 2003).
Evidence surrounding transition services and aftercare treatment has been so
overwhelming that multiple government agencies have updated treatment policy to reflect an
emphasis on aftercare. The Bureau of Justice Assistance (BJA) now requires that state grant
programs give preference to prison facilities that provide aftercare services. Likewise, the Office
of National Drug Control Policy (ONDCP) standard of care requires that community-based
aftercare treatment have a minimum duration of six months (Urban Institute Justice Policy
Center 2006; Visher & La Vigne 2003).
Despite these new policies and ample evidence demonstrating the benefits of transition
services, parolees with SUD and SMI typically receive minimal-to-no follow-up upon release
from correctional facilities, which significantly decreases their likelihood of successful
reintegration, and increases their likelihood of criminal recidivism (Fisher et al. 2014).
Moreover, transition services is one of the least frequently offered services in U.S. prisons
(Kubiak, Zeoli, & Essemacher 2011). Many correctional facilities and parole agencies that
provide transition services are ill equipped to assess, diagnose, and refer SUD and SMI parolees
to appropriate community-based drug and mental health aftercare treatment (Ducharme et al.
2013). Additionally, because transition services and community-based aftercare treatment
involve different “systems” of organization (community and corrections) they are commonly
overlooked (Simpson 2004). This can be the result of a lack of funding, organizational
complexity, and “service delivery gaps” due to fragmented coordination between these two
organizations, all of which put soon-to-be parolees at risk of not receiving proper care and
9

services. Studies indicate that an absence of collaborative relationships between therapeutic
communities and correctional facilities is significantly associated with poor aftercare treatment
outcomes. Weak collaboration has led to many missed opportunities to provide drug and mental
health treatment, and increases parolees’ likelihood of criminal recidivism (Fletcher et al. 2009;
Freudenberg 2001).
Co-Occurring Disorders
At an individual level, the term co-occurring disorder (COD) refers to persons with one
or more SUD and one or more SMI that exist independently of the other (Sacks & Ries 2005).
However, because an individual may not always meet DSM criteria for a diagnosable mental
health or substance use disorder—ruling out a potential COD diagnosis—experts recommend
using a “service definition” of COD, which includes individuals in a “prediagnosis” stage who
have one established disorder (mental or substance) who show symptoms an additional disorder,
or are at risk of developing one (SAMHSA 2006).
COD Treatment
Researchers using data from the National Comorbidity Survey (NCS) reported that less
than 40 percent of Americans with COD have ever received professional care (SAMHSA 2016).
As a group, persons with COD demonstrate lower rates of treatment entry (Verduin et al. 2005),
show poorer retention in therapy (Baillargeon et al. 2010; Curran et al. 2003), and less successful
treatment outcomes such as hospitalization and drug relapse, compared to persons with SMI or
SUD only (Krupsi et al. 2009). This can be partially attributed to a lack of specialized
screenings and treatments for COD utilized by community-based drug treatment facilities, and
poor collaboration between the mental health and addiction therapeutic communities. Improper
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practice decreases the likelihood that a COD will be diagnosed or treated (McGovern et al. 2010;
Peters et al. 2015; Priester et al. 2016).
Offenders with COD
Compared to a single-disorder, COD is more strongly associated with a larger variety of
individual and social health risks, including unemployment, homelessness, drug relapse and
overdose, and suicide (Mueser, Drake, & Miles 1997; Osher & Drake 1996; Peters et al. 2015).
COD is also associated with increased criminogenic behavior: persons with COD are more likely
to be arrested and incarcerated (Monahan et al., 2000, 2001, 2005), and two to three times more
likely to commit acts of violence (Drake et al. 2006; Peters et al. 2015; Taxman et al. 2008).
Additionally, offenders with COD serve longer sentences, violate parole, and recidivate sooner
than offenders with SUD or SMI (Morgan et al. 2010; Skeem, Nicholson, & Kregg 2008). These
findings are verified by the increasing rates of SUD and SMI (co-occurring and independentlyoccurring) among the correctional population.
Many experts note that COD is the rule than the exception in correctional settings (Grant
et al. 2004; Peters, Rojas, & Bartoi in press; Peters et al. 2015). BJS reports that approximately
42 percent of prison inmates and 49 percent of jail inmates experience COD (James & Glaze
2006). Across individual studies, researchers have estimated that a minimum of 42 percent of
state prisoners experience symptoms of COD (Mumola & Karberg 2006; Wood 2014), and up to
80 percent of state prisoners with SUD also experience co-occurring mental health problems or
SMI (Sacks and Ries 2005; Taxman et al. 2008).
Similar to SMI and SUD offenders, offenders with COD are severely undertreated in
prison facilities and their symptoms are regularly undetected. As a group, offenders with COD
are less likely to receive any drug or mental health treatment than offenders with SUD and SMI.
11

Additionally, prison-based COD treatment is typically unavailable. Compared to communitybased corrections settings, jails, probation, and parole systems are significantly less likely to
provide screenings, needs assessments, and treatment for COD (Taxman et al. 2008). Even when
correctional facilities do offer separate mental health and drug treatment, evidence-based
screenings and specialized treatment for COD are underutilized.
Prison-Based COD Treatment Research
Offenders with COD tend to be ignored in treatment research. Very few controlled
studies have examined the efficacy of prison-based treatment, transition services, and aftercare
treatment for this population (Harrison & Martin 2003; Peters et al. 2015; Wood 2014), and
research on offender COD screening tools is a relatively new development. Literature that does
exist is not widely disseminated, creating a research-to-practice gap in prison treatment settings
(Lurigio et al. 2003; Peters & Petrila 2004). Although experts have agreed that prison-based
treatment can lead to successful changes in drug use and mental health, what remain in question
are the significant differences between treatment models and processes, where they can be
improved, and to what degree they can significantly improve health and recidivism outcomes for
offenders with COD (Simpson 2004).
Research Needs
In addition to prison-based treatment, there is limited literature on transition services and
for offenders with COD. Research gaps methodological flaws prevent experts from drawing
conclusions about effective components transition services. For instance, experts have called for
an increase in both the variety and quality of outcome measurement in treatment literature that
addresses COD (Pelissier, Jones, & Cadigan 2007), adding that multiple measures of behavioral
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outcomes and criminal recidivism should be utilized in single studies to ensure the integrity of
research findings (Harris, Gingerich, & Whittaker 2004).
Many researchers fail to address the conceptual differentiation between transition
services and community-based aftercare treatment. In a review of transition and aftercare SUD
treatment research, Pelissier et al. (2007) noted several instances when research articles did not
provide any type of description or conceptualization of therapeutic models or treatment
measures. Key aspects of therapy such as duration, intensity, and setting all contribute to the
effectiveness of a therapy and should be explicitly outlined in study methodology. To omit
conceptualizations and descriptions of such can be confusing and misleading, especially in the
case of similar yet distinct services such as transition and aftercare. Additionally, poor
methodology makes it difficult to compare results across studies and evaluate program
effectiveness.
Treatment duration, intensity, and setting all affect program success; to leave out
treatment descriptions when describing a model of care and research findings, makes it difficult
to compare results across studies, and hinders a body of literature from approaching research
consensus. In order to determine which models and components of transition services are most
affective at treating parolees with COD, program conditions and measures of treatment should be
explicitly outlined in study methodology.
COD Transition Services and Community-Based Aftercare Treatment
Unfortunately, many offenders with COD fail to receive transition services prior to
discharge, and upon release from correctional facilities, most struggle to initiate and complete
community-based aftercare treatment (Earthrowl et al. 2003; Kubiak et al. 2010; Sacks et al.
2012; Smith, Baxter, & Humphreys 2003). For example, one study of California offenders found
13

that only 34 percent of parolees in transition services who received referrals to community-based
aftercare actually entered treatment, and 45 percent of those dropped out before completing 90
days of treatment (Hall et al. 2003).
While research on COD transition services and aftercare treatment is still in early
development, there are some promising studies. Similar to offenders with SUD, studies of
inmates with COD who receive treatment in correctional settings followed by formal communitybased aftercare show significantly reduced levels of substance use and criminal recidivism
(Sacks et al. 2004; Sacks et al. 2012). In particular, research on a modified TC model for COD
has shown significant reductions in the likelihood of recidivism for participants (Sacks et al.
2012). One study of parolees with COD who received prison-based drug treatment as well as
community-based aftercare reported that at 12-months post release, reincarceration rates for the
treatment group were 50 percent lower than the control group (19 percent vs. 38 percent, when
controlling for demographic measures and treatment received during incarceration).
Summary
Offenders with COD face several individual and social health risks. Research shows that
prison-based COD treatment accompanied by transition services and aftercare treatment
significantly decreases offenders’ likelihood of drug relapse and criminal recidivism. In order to
improve COD offender outcomes, it is crucial to understand which models of transition are most
predictive of engagement in community-based aftercare treatment and reduced criminal
recidivism.
Experts have noted that research on transition services is limited and community based
treatment for offender populations are “typically not well grounded in evidence-based practices”
(George et al. 2012:2; Taxman et al. 2008; Wood 2014). The purpose of this study is to extend
14

our understanding of transition services for parolees with COD. The present study tests the
effects of a transition service program on drug use and criminal recidivism outcomes for parolees
with COD. Secondary data from previously conducted research on the effects of Transition Case
Management (TCM), a transition service program model developed for SUD offenders
(Prendergast & Cartier 2004) is analyzed.
Hypotheses
Using logistic regression analysis the present study tested three hypotheses.
H1 The odds of rearrest are lower for parolees with COD who receive TCM than for parolees
with COD who receive SR.
H2 The odds of reincarceration are lower for parolees with COD who receive TCM than for
parolees with COD who receive SR.
H3 The odds of illicit drug use are lower for parolees with COD who receive TCM than for
parolees with COD who receive SR.
DATA & METHODS
Study Design
This study analyzed data from the CJ-DATS Transition Case Management Study
(Prendergast & Cartier 2004), a short-term longitudinal study of a transition service intervention
for recently paroled offenders with SUD, who received drug treatment while incarcerated. The
TCM was developed to enhance system level service organization, test a transition service model
meant to increase the quality of transition services from prison to community, and improve
client-level outcomes such as aftercare participation and completion, substance use relapse, and
criminal recidivism (Prendergast & Cartier 2004).
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Sample
The target population for this study was two-tiered, with organizational and individual level
samples. First recruited were criminal justice systems with therapeutic community partners that
offered specific cognitive-behavioral treatments both in prison and during transition service
administration. Once these sites were selected, the individual-level sample was recruited from
each participating organization. The individual-level sample consisted of adult felony offenders
who received prison-based treatment for an identified substance use, who also had a referral for
community treatment upon discharge. In total, there were five participating state research sites
across the United States, with 200 offender participants from each organization (Prendergast &
Cartier 2004).
Recruitment
Researchers utilized monetary incentives to increase response rates and avoid study
attrition. Participants were paid $10 to complete a baseline assessment and $25 to complete at
three-and nine-month post release interviews. Additionally, those who completed both
assessments were paid an additional $10, and participants who voluntarily provided urine
samples were given $5 for each test. Follow-up incentives were also provided in the form of
grocery script or other noncash monetary gifts.
Treatment Conditions
A comparison study design placed consenting respondents in two randomized treatment
groups: (1) a control group that received SR services and (2) a treatment group that received
TCM. Participants in the control group received Standard Referral services, which includes a
referral to a community-based treatment, and upon release, standard parole supervision and
services (Prendergast & Cartier 2004) (it should be mentioned that the SR services offered at
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each site were all evidence-based models of care—a prerequisite for participating in the study).
Participants in the treatment group received the TCM intervention which consists of two phases:
first, each participants was assigned a TCM case manager and began receiving transition services
approximately two months prior to release, and continued to have weekly sessions with their
case managers for the first three months of parole. The second phase occurred for the first three
months of parole and involved case management, monitoring, and facilitating access to
designated treatments and services (Prendergast & Cartier 2004). Group assignment took place
during Wave I at baseline interviews. A computer program used gender, race, risk of recidivism,
substance use severity, and type of treatment institution as variables in “urn” randomization
(Prendergast & Cartier 2004; Stout et al. 1994).
Data Collection
Data were collected at three assessment points: Wave I baseline interviews took place in
correctional facilities and occurred approximately three months prior to offenders’ release;
Waves II and III consisted of follow-up interviews with parolees at three- and nine-months post
release. The final sample size upon completion of Wave I baseline interviews was 812.
Measures
Outcome Variables
Criminal recidivism. For the purpose of this study, criminal recidivism was defined as
any rearrest or reincarceration that occurred within three- to nine-months post release. At Wave
II (three-months post release), data on rearrest and reincarceration were collected via selfreporting from follow-up interviews with parolees and their case managers. At Wave III (ninemonths post release), rearrest and reincarceration data were supplemented with official criminal
justice data records. In total, two variables were created to measure criminal recidivism: (1) any
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rearrest during the first and second recall periods (Waves II & III), and (2) any reincarceration
during the first and second recall periods. These were binary variables, with “0” indicating no
rearrest or reincarceration during either recall periods, and “1” indicating any rearrest or
reincarceration during either recall periods.
Drug use. Self-reports and urine analysis were collected to measure parolees’ drug and
alcohol use at Waves II and III. The only exceptions to collecting urine samples were in the case
of parolee reincarceration or if there were cooperation difficulties with jail and prison
administrators. One comprehensive, binary variable was created to represent any post release
drug or alcohol use during the three- to nine-months post release period (any post release drug or
alcohol use = 1, no post release drug or alcohol use = 0).
Explanatory Variables
TCM participation. A dummy variable was used to identify the treatment and control
groups (TCM = 1, SR = 0).
COD. Because the TCM manual did not provide information regarding the professional
COD diagnoses participants’ received following their mental health assessments, the present
study used a “service definition” of COD to identify positive cases. As mentioned previously, a
service definition of COD includes individuals in a “prediagnosis” stage—persons with one
established disorder (in this case SUD)—who show symptoms of one or more additional SMI
disorders (SAMHSA 2006). If participants’ mental health test scores met a certain numeric
threshold they were identified as a positive COD case. Additional information about this
threshold is provided below.
Mental health was measured at Wave I during baseline interviews using the Brief
Symptom Inventory (BSI®), an evidence based, standardized mental health screening instrument
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used to diagnose nine symptom dimensions (Somatization, Obsessive-Compulsive, Interpersonal
Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and
Psychoticism) (Derogatis 1993b). Extensive analysis of the BSI has confirmed the internal
consistency reliability, test-retest reliability, convergent and discriminant validity, predictive
validity, and internal structure and construct validity of this measurement tool (Derogatis 1993a;
Derogatis & Cleary 1977; Derogatis, Rickels, & Rock 1976; Harmon 1967; Nunally 1970).
The BSI is a 53-item inventory of symptoms such as “feeling lonely”, “nervousness or
shakiness”, or “trouble getting your breath”. Participants rate their experience with these items
on a 5-point Likert-scale of distress, ranging from “not at all” = 0 to “extremely” = 4.
Different symptom dimensions are associated with different inventory items, and
measured by grouping these items together to calculate a dimension score. This is done thorugh
a two-step process; first by calculating a raw score, which is the total sum of the values attributed
to each item in a dimension’s series, divided by the total number of items endorsed (for example,
Depression has 6 items, but if only 5 symptoms are endorsed, meaning it has been assigned a
value “1” or greater, the total sum is divided by 5 items, rather than 6) (Derogatis 1993b).
#
Second, participants’ raw scores are converted into standardized area T scores, which
have a mean of 50 and a standard deviation of 10 (Derogatis 1993). T scores were compared to
adult male and female nonpatient average T scores distributions; if respondents’ T scores were
equal to or greater than 63 (the numeric threshold for “caseness”), they were identified as a
positive case of COD.
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This formula was repeated for all nine symptom dimensions, and nine binary variables
were created to measure respondents’ positive or negative “case” status for each dimension (i.e.,
Depression noncase = 0, Depression positive case = 1). The nine symptom dimension variables
were then manipulated to construct one final dichotomous measure that represented all
participants who were positive cases for one or more of the nine symptom dimensions (noncase
= 0, positive case = 1).
Before proceeding, it is important to address potential concerns surrounding the
measurement of intangible phenomena, such as the COD status of offender participants. It is
impossible to account for every possible symptom or manifestation of an SMI, and many
offenders have symptoms that do not conform to conventional notions of a particular disorder, or
are not addressed in established criteria (Morrison 2014). Furthermore, the use and abuse of
substances can both cause and exaggerate mental disorders, making it especially difficult to
separate and distinguish symptoms as being two or more comorbid disorders (disorders that are
interdependent) or two or more independently COD’s (Morrison 2014).
The justification for this study’s operational definition of COD is also worth discussing.
Because of the difficulty in reaching a diagnosis with absolute surety, SMI and mental health
symptoms are typically charted on a broad continuum of severity. While the measure of mental
health in this study is technically a dichotomous variable, values were established according to a
defined diagnostic construct of “caseness” that falls along a spectrum of normal, representative
sample score distributions. This concept is referred to as “implied hierarchy,” when a certain
criteria or threshold is established (in this case a T score threshold), in order to apply a diagnostic
label (Thornicroft & Tansella 2010:240). This is one of the principal aims of epidemiological
research—to estimate prevalence of a particular disorder or condition (Thornicroft & Tansella
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2010), and the creator of the BSI considers an operational definition of caseness as “fundamental
to screening research of all kinds” (Derogatis 1993b:31). As such, it is common in mental health
research to identify a threshold score on a dimensional scale in order to differentiate between
cases and noncases, and experts note the utility in this practice (Thornicroft & Tansella 2010).
Conversely, it can be argued that this measure does not allow for sensitivity to minor
deviations from the T score threshold for caseness. Although, considering the high frequency of
respondents whose symptom dimension scores meet the numerical definition of caseness, and
similar distribution to estimated population rates, it is likely that the study’s measure of mental
health has effectively captured those who experience diagnosable symptoms of a COD.
Additionally, the BSI distribution scale is arguably more clinically relevant than other mental
health instruments; empirical investigation has confirmed the symptom dimension caseness
sensitivity of the BSI across several populations, including offenders (Singer et al. 1995;
Tansella & Thornicroft 1996; Zabora 1990). It may be helpful to think of the present study’s
measure of mental health as an indicator variable, representing those respondents whose BSI
symptom dimension scores are severe enough to meet a reliable and internally valid numerical
threshold representing diagnosable severity.
Addiction severity. Substance use and addiction severity were assessed at Wave I during
baseline interviews using the TCU Drug Screen II (TCUDS II). The TCUDS II is an evidencebased, standardized assessment and treatment evaluation tool, created to measure SUD among
offender populations (Knight 2007; Prendergast & Cartier 2004; Simpson & Joe 1993). Several
studies have certified its predictive validity, sensitivity, and accuracy in comparison to other
standardized addiction screening instruments (Knight 2007; Peters, Bartoi, & Sherman 2000),
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and confirmed its particular utility when determining eligibility for treatment services in criminal
justice settings (Knight, Simpson, & Hiller 2003; Peters et al. 2000).
The TCUDS II is comprised of fifteen yes/no questions that are based on DSM addiction
criteria, with diagnosis protocol corresponding approximately with classifiable DSM drug
dependence (American Psychiatric Association 2013). Items 1 through 9 measure addiction
severity, while items 10 through 15 provide descriptive information regarding use and frequency
of particular substances. Total scores can range from 0 to 9, with a score of 3 or greater
indicating a relatively severe drug-related problem. In previous CJ-DATS studies the TCUDS II
was coded as an indicator variable representing severe and non-severe addiction (score of 3 or
greater = 1, score of 2 or less as = 0). The present study kept the TCUDS II in its original format
as a numerical index measure with values ranging from 0 through 9.
Recidivism risk. Risk of Recidivism was measured during Wave I interviews using the
Lifestyle Criminality Screening Form (LCSF) (Walters 1990, 1991, 1998). The LCSF is an
evidence-based instrument used to assess risk of recidivism. Through statistical analysis, the
screening form is confirmed to have strong internal consistency (Cronbach alpha= .70) as well as
test-retest reliability (r=.93) (Walters & McDonough 1998). The test is composed of 14-items
that measure likelihood of recidivism; topics in the questionnaire address irresponsibility, selfindulgence, criminal history, and social rule breaking. Scores lower than 7 are classified as “low
risk” for recidivism, with 7 through 9 classified as “moderate risk”, and scores of 10 or greater
considered “high risk”. The full-scale score of the LCSF was used in statistical analysis, with
values ranging from 3 through 19.

22

Demographic Variables
Various demographic variables were used as control measures in the regression analysis,
including sex, race, age, marital status, and educational attainment. Rather than create a variable
with multiple race categories, the race measure was a dichotomous variable that compared whites
to three other racial groups (blacks, Hispanics, and Native Americans—other ethnic groups were
not frequent enough in the dataset to include in the analysis); white was coded as “1”, and
nonwhite was coded as “0”. The original Wave I intake survey allowed participants to mark
multiple categories to identify their race, making it difficult to create a variable with mutually
exclusive race categories. To adjust for this, white participants who identified as biracial
Hispanic, Native American, or black were assigned to the “nonwhite” category. Analysis
conducted to test the effects of this dichotomous race variable showed no significant outcome
differences when compared to a race measure that included biracial participants in the “white”
category, and a variable with three mutually exclusive racial categories.
Sex was coded to identify females as the comparison group (female = 0, male = 1).
Consistent with previous criminological studies (Belenko & Houser 2011; Fisher et al. 2014),
educational attainment was coded as a dummy variable, based on whether the respondents
graduated from high school or earned a GED equivalent (no = 0, yes = 1). Marital status was
also a dichotomous variable that measured whether a person was single, legally married or living
as married (not married = 0, married or living as married = 1). Age was a scale variable coded in
years.
Analytic Plan
In the previous TCM study, treatment effects on criminal recidivism and drug relapse
outcomes were estimated using multilevel models, hierarchical linear models, random-effects
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mixed regression, Bernoulli distribution link test, and cox proportional hazard regression. Group
differences were analyzed at two specific time points, to test group changes over time. Some
models were estimated to allow for within group correlations, and other models used covariates
to control for baseline differences between treatment and control groups (Prendergast & Cartier
2004). Because none of these regression models predicted statistically significant associations
between explanatory and outcome variables, the present study used general binary logistic
regression.
This study used two types of binary logistic regression models to estimate the odds ratios
for three outcomes (rearrest, reincarceration, and drug use). The first logistic regression model
estimated the effects of TCM participation, COD, sex, race, age, marital status, educational
attainment, addiction severity, and recidivism risk, on rearrest, reincarceration, and drug use
outcomes. The second logistic regression model was the same as the first, with the exception of
adding an interaction term between TCM participation and COD.
The interaction term was used to account for effect modification in the regression models
when testing the associations between the explanatory and outcome variables. This function will
help to determine if COD caseness plays a role in the association between participating in TCM
and rearrest, reincarceration, and drug use, or if these two explanatory variables are
independently associated with the outcome variables (Hoffmann 2010; Hoffmann 2015).
Missing Data
Interviews and assessments were completed with an 84 percent follow-up rate at Wave II
(n = 685), and an 83 percent follow-up at Wave III (n = 678). Forty-seven participants (25 TCM,
22 SR) were either not released from prison in time to participate in transition services and
community-based aftercare treatment, or were paroled to a county or state where TCM services
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were not available. Despite study attrition, official rearrest and reincarceration records were
obtained to reconstruct the outcome data and maintain a sample size of 806. Through interim
analyses and imputation strategies it was determined that missing cases due to drop out did not
compromise the integrity of the data or impact heterogeneity between the treatment and control
groups (Prendergast & Cartier 2004). Additionally, CJ-DATS researchers determined that the
TCM and SR groups were comparable on demographic, criminal recidivism and post release
drug use variables (Prendergast & Cartier 2004). Missing data was also supplemented with
various statistical functions. When the frequency of missing data for particular variables was
small, researchers employed mean substitution; if variables showed extensive patterns of missing
data the estimation-maximization (EM) algorithm was used to provide maximum likelihood
estimates of incomplete data (Little & Rubin 1987). In the case of missing data for outcome
measures, data were analyzed using mixed regression models and generalized estimating
equations, which accommodate missing data in longitudinal datasets (Hoffmann 2015;
McPherson et al. 2013).
RESULTS
Descriptive Results
Descriptive statistics for the data are presented in Table 1; variables in the table include
rearrest, reincarceration, drug use, TCM participation, COD, sex, race, age, marital status,
educational attainment, addiction severity, and recidivism risk.
Total Sample
Comparison descriptive statistics are displayed in Table 2. The sample was 76 percent
male, 26 percent white, with a mean age of 34.2. About 31.9 percent of the sample graduated
from high school or earned a GED, and 17.4 percent were legally married or cohabiting.
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Seventy-eight percent of the sample had BSI scores that met the numerical definition of caseness
for at least one of the nine symptom dimensions; the mean addiction severity score was 5.7, and
mean recidivism risk score was 11.3.
[Table 1 About Here]
COD vs. SUD Only
The COD group was about 75 percent male, 26 percent white, with a mean age of 34.2.
In comparison, the SUD group was almost 87 percent male, while race (26.2 percent white) and
mean age were about the same. Among the COD group, 32.3 percent graduated high school or
earned a GED, while only 27.9 percent of those with SUD graduated. About 17 percent of the
COD group was legally married or cohabiting, in comparison to 24.6 percent of the SUD group.
Those with COD were at a higher risk for recidivism than the SUD group with a mean score of
11.3 compared to 10.7 for SUD parolees. Those with SUD had slightly higher addiction severity
than the COD group (SUD mean score of 5.9 vs. COD mean score of 5.7). The SUD group also
had a higher rearrest rate at 70 percent compared to the COD group at 63.5 percent. Conversely,
the COD group had a higher reincarceration rate at 44.7 percent, with the SUD group at 40.4
percent. Approximately 25 percent of those with SUD and 26.6 percent of those with COD
tested positive for drug use.
[Table 2 About Here]
Rearrest
The first hypothesis—that the odds of rearrest are lower for parolees with COD who
receive TCM than for parolees with COD who receive SR—was tested through the estimation of
two regression models. The first model estimated the independent effects of TCM participation
on rearrest while controlling for the effects of COD, sex, race, age, marital status, educational
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attainment, addiction severity, and risk of recidivism (summarized in Table 3). The results
showed no significant differences in odds of rearrest between the treatment and control groups
(OR = .89, p=.44). Likewise, there were no significant differences in odds of rearrest for any of
the control variables.
Symptoms of COD as a Moderator
The second model estimated the odds of rearrest with the addition of the interaction term
TCM participation x symptoms of COD, while holding constant the effects of sex, race, age,
marital status, educational attainment, addiction severity, and risk of recidivism (summarized in
Table 3). While the odds of rearrest technically increased from .89 in the first model to 1.56 in
the second, these differences were not statistically significant.
[Table 3 About Here]
Reincarceration
The second hypothesis—that the odds of reincarceration are lower for parolees with COD
who receive TCM than for parolees with COD who receive SR—was tested by regressing TCM
participation on reincarceration, while holding constant the effects of COD symptoms, sex, age,
race, marital status, educational attainment, addiction severity, and risk of recidivism
(summarized in Table 4). Overall, the regression effect was not statistically significant.
Symptoms of COD as a Moderator
The second model estimated the odds of reincarceration by adding the interaction term
TCM participation x symptoms of COD, while controlling for the effects of sex, race, age,
marital status, educational attainment, addiction severity, and risk of recidivism (summarized in
Table 4). Results showed no significant differences in reincarceration.
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[Table 4 About Here]
Drug Use
The third hypothesis predicted that the odds of drug use are lower for parolees with COD
who receive TCM than for parolees with COD who receive SR (summarized in Table 5). This
was tested by regressing TCM participation on drug use, while controlling for the effects of COD
symptoms, sex, race, age, marital status, educational attainment, addiction severity, and risk of
recidivism. The primary relationship between TCM and drug use was not significant, but age
significantly predicted likelihood of drug use, with each year increase associated with a 5 percent
decrease in the odds of drug use (OR = .95, p = .000).
Symptoms of COD as a Moderator
The second model used the interaction term TCM participation x symptoms of COD to
predict the odds of drug use, while controlling for the effects of sex, race, age, marital status,
educational attainment, addiction severity, and risk of recidivism (summarized in Table 5). In
this model, the primary relationship between TCM participation and drug use was insignificant;
the odds ratio for the TCM x COD interaction term was also insignificant. Age was the only
variable that remained a significant predictor, with each year increase associated with a 5 percent
decrease in the odds of drug use (OR = .95, p = .000).
[Table 5 About Here]
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DISCUSSION
Researchers have estimated that up to 80 percent of state prisoners with SUD experience
co-occurring mental health problems or SMI, while overall, a minimum of 42 percent of state
prisoners experience symptoms of COD (Mumola & Karberg 2006; Sacks and Ries 2005;
Taxman et al. 2008; Wood 2014). Offenders with COD are more vulnerable than both general
offenders and offenders with SUD or SMI; they are more likely to experience drug relapse and
overdose, and are rearrested and reincarcerated sooner (Baillargon et al. 2009; Morgan et al.
2010; Skeem et al. 2008; Wood 2014).
Previous studies have established the importance of transition services for offenders with
SUD (Urban Institute Justice Policy Center 2006; Visher & La Vigne 2003). Furthermore,
research shows that these services are especially beneficial when offenders have completed
prison-based drug treatment (Earthrowl et al. 2003; Knight, Simpson, & Hiller 1999; Martin,
Butzin, Suam, & Inciardi 1999; Sacks et al. 2012; Simpson 2004; Wolff et al. 2002). In contrast,
offenders with COD rarely receive prison-based treatment or transition services prior to
discharge and upon release from correctional facilities (Earthrowl et al. 2003; Kubiak et al. 2010;
Sacks et al. 2012; Smith, Baxter, & Humphreys 2003). Models of transition services have been
developed for COD offenders but show limited success, and research on these services remains
in early development.
The aim of the present study was to extend criminologists’ and treatment experts’
understanding of transition services for offenders with COD. Using data from the CJ-DATS
TCM Study on parolees with SUD (Prendergast & Cartier 2004), this study conducted further
analysis on the sample by examining the frequency of COD, and accounting for parolees’ COD
status when testing the effects of TCM. Outcome measures analyzed in the study included drug
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use, rearrest, and reincarceration between three- and nine-months post release. Previous studies
of TCM accounted for COD during group randomization, but not in any statistical analysis.
Researchers found no statistically significant differences between parolees who received TCM
and those who received SR and authors recommended that enhancements to their study model be
conducted in the future (Prendergast & Cartier 2004; Prendergast et al. 2011).
The findings of the present study echo previous TCM research; when accounting for
parolees’ COD there were no statistically significant differences between TCM and SR groups in
the areas of drug use, rearrest, and reincarceration. Coupled with previous findings, this
evidence further indicates that TCM is not a suitable model of care for SUD offenders with cooccurring SMI. This is not completely unexpected, considering the lack of significant findings in
previously conducted examination of TCM. While the results of this analysis were not
statistically significant, it is worth noting that in some cases, parolees who received SR actually
showed lower odds of drug use and criminal recidivism outcomes than parolees who received
TCM. This further suggests that TCM is unremarkable in comparison to the evidence-based SR
services.
Limitations
It is important to address potential concerns surrounding this study that may limit the
extent of inferences to be made from the data. Because data on the frequency of parolees
diagnosed with COD was not freely available, it was impossible for this study to report an
accurate percentage of parolees from the original sample with COD. Additionally, it should be
noted that as a requirement, parolees who were diagnosed with COD were only permitted to
participate if their assigned correctional facility could provide a referral to a community program
specialized for COD (Prendergast & Cartier 2004). This requirement could have potentially
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decreased the frequency of COD participants, creating the potential for biased and inaccurate
findings.
Requiring study participants to drop out if they did not have referrals to specialized COD
aftercare treatment leads us to infer that aftercare treatment is equally or more influential than
transition services on parolee drug use and criminal recidivism outcomes. Even when transition
services are specialized for COD, unless parolees also receive specialized aftercare, on its own,
transition services may be ineffective. Because the participants with COD received or were
required to have a referral to specialized, evidence-based aftercare treatment, it further points to
the conclusion that TCM is not an effective transition model for offenders with COD, even if it is
followed-up with specialized COD aftercare treatment.
Future Studies
Measuring and Testing Mental Health
Although methodological justification was discussed in detail in a previous section, it is
worth mentioning again that the mental health measures used in this analysis could be more
refined in future, more elaborate studies.
Using the T scores for all nine symptom dimensions of the BSI to measure mental health
would have allowed for a wider spectrum of empirical investigation. Using T scores would
ensure more accurate representations of symptom dimension distributions, as well as provide
insight about the specific symptoms offenders with COD experience. Additionally, future
studies that use BSI T scores could test which COD’s are more strongly associated with or
predictive of certain outcomes. A knowledge of which symptom dimensions are significantly
associated with a lower likelihood of participating in aftercare treatment, or an increased risk for
drug use and criminal recidivism would inform decisions regarding the types of transition and
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aftercare services that should be a priority for SUD offenders, depending on the type of COD
they experience (i.e., depression, OCD, anxiety).
It has been established that future studies should measure mental health at multiple points
in time in order to accurately monitor changes in symptom severity that may be caused or
exaggerated by participants’ drug and alcohol use (Trauer 2010). While follow-up interviews in
Waves II and III included psychiatric reevaluation with the BSI, data were not freely accessible,
preventing this study from using multiple and longitudinal measures mental health. Future
follow-up studies with access to this data, and new studies that collect such data, would increase
the quality of methodology and depth of insight by including these measures in their analysis.
A deep understanding of the transition process for parolees with COD is lacking in COD
treatment research. Testing the association between mental health and drug use overtime, the
effects of transition services and aftercare treatment on changes in mental health and drug use,
and creating interaction terms between these measures to predict criminal recidivism
longitudinally, would all be worthwhile analyses.
Likewise, including BSI T scores as outcome measures predicted by transition and
aftercare service participation would help experts determine which models and combinations of
models are most effective, over time. Conversely, time series or longitudinal measures of BSI T
scores could also be used as explanatory variables, used to predict criminal recidivism and
prolonged participation in community-based aftercare treatment.
Conclusion
This study was conducted to reassess TCM as a suitable model of care for offenders with
COD. These findings, as well as previous examination of the TCM, show no statistically
significant differences between treatment and control groups in the areas of drug use, rearrest,
32

and reincarceration. Considering prior research that demonstrates the benefits of transition
services for general offenders and offenders with SUD, the nonsignificant findings of this study
point to the ineffectiveness of this particular transition model, rather than the ineffectiveness of
COD transition services in general. These results call for future examination of new, specialized
transition service models for parolees with COD. It is critical to design and implement evidencebased models of transition services for offenders with COD, in order to effectively increase their
participation in community-based aftercare treatment, decrease COD symptom severity, future
drug use, and rates of criminal recidivism.
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TABLES
Table 1: Summary of Measures

Range Mean Std. Dev.
Outcome Variables
Any Rearrest

0-1

.48

.50

Any Reincarceration

0-1

.64

.48

Any Drug Use

0-1

.29

.45

Treatment Group
Any Mental Health
COD

0-1

.50

.50

0-1

.78

.41

Male

0-1

.78

.43

White

0-1

27.7

.45

High School Graduate

0-1

.32

.47

Married or Cohabiting

0-1

0.17

0.38

18-66

34.2

9.1

Addiction Level

0-9

5.7

2.8

Recidivism Risk

0-19

11.3

2.9

Explanatory Variables

Age

Sample n = 811
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Table 2: Sample Descriptives, COD vs. SUD Only

Total

SUD

COD

Range

%

%

%

Any Rearrest

0-1

64.0

70.0

63.5

Any Reincarceration

0-1

44.2

40.4

44.7

Any Drug Use

0-1

28.8

25.0

26.6

Treatment Group

0-1

50.5

54.1

50.1

Male

0-1

76.0

86.9

74.9

White

0-1

27.7

26.2

28.0

High School Graduate

0-1

31.9

27.9

32.3

Married or Cohabiting

0-1

17.4

24.6

16.9

Total

SUD

COD

Range

Mean

Mean

Mean

Age
Addiction Level

18-66
0-9

34.2
5.7

34.2
5.9

34.2
5.7

Recidivism Risk

0-14

11.3

10.7

11.3

Sample n = 811
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Table 3: Logistic Regression: Rearrest Predicted by TCM Participation (n = 806)

Model 1

Key Independent Variables
TCM
COD
Interaction Term
TCM#COD
Controls
Male
Age
White
Marital
High School Graduate
TCUD Score
LCSF Score

Model 2
P-Value

Odds Ratio

P-Value

Odds Ratio

.89
.83

.44
.49

1.56
1.15

.40
.73

-

-

.54

.19

.94
.99
.94
.98
.94
1.02
1.02

.75
.45
.94
.93
.68
.55
.44

.95
.99
.94
.96
.93
1.02
1.02

.67
.98
.67
.65
.68
.96
.97

n=806
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Table 4: Logistic Regression: Reincarceration Predicted by TCM Participation (n = 806)
Model 1
Odds Ratio
Key Independent Variables
TCM
COD
Interaction Term
TCM#COD
Control Variables
Male
Age
White
Marital
High School Graduate
TCUD Score
LCSF Score

Model 2
P-Value

1.05
.73

.75
.30

.81
.99
.99
.86
1.10
1.00
1.02

.28
.26
.94
.44
.56
.70
.85

n=806
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Odds Ratio

P-Value

1.42
.85

.56
.72

.73

.60

.82
.99
.98
.85
1.10
.99
1.00

.29
.28
.93
.42
.56
.80
.86

Table 5: Logistic Regression: Drug Use Predicted by TCM Participation (n = 806)
Model 1
Odds Ratio
Key Independent Variables
TCM
COD
Interaction Term
TCM#COD
Control Variables
Male
Age
White
Marital
High School Graduate
TCUD Score
LCSF Score

.76
1.12

Model 2
P-Value
.22
.78

1.16
.95
.73
.73
1.03
1.02
.95

.67
.000*
.21
.32
.90
.56
.18

n=806
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Odds Ratio

P-Value
1.64
1.82

.55
.38

.44

.34

1.17
.95
.73
.71
1.02
1.02
.95

.58
.000*
.19
.28
.92
.56
.18

